Hydrogen Sulfide Gas from CSE Protein Emerges as Potential Alzheimer’s Treatment Target
Johns Hopkins researchers identify CSE enzyme and hydrogen sulfide as potential targets to prevent Tau protein-related Alzheimer’s progression.
Read More
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Health
Russian Bots, Kremlin Agitprop, and Meta’s Blind Eye: The Disinformation War Over Hungary’s 2026 Election
As Hungary votes April 12, Russian GRU operatives, bot networks, and AI-generated deepfakes flood Facebook while Meta looks the other way. A comprehensive investigation into the Kremlin’s election interference machine and Zuckerberg’s complicity.
Read More
Studies Confirm Direct Oral Challenge Safely Delabels Penicillin Allergies in Hospitals
Studies show direct oral challenge safely removes penicillin allergies in hospitals, increasing penicillin use 13-fold within 90 days.
Read More
Stopping Ozempic or Wegovy Reverses Cardiovascular Benefits, New Study Warns
A study finds stopping Ozempic or Wegovy for six months or more reverses cardiovascular benefits in type 2 diabetes patients.
Read More
UK Biobank Study: Highest Physical Activity Levels Cut Cancer Risk by 26% Across 13 Types
A UK Biobank study found that highest physical activity levels reduce risk of 13 cancer types by 26%, based on accelerometer data.
Read More
Novo Nordisk’s Oral Wegovy Gains FDA Approval, 25mg Semaglutide Tablet Launches for Weight Management
The FDA approved Novo Nordisk’s 25 mg oral Wegovy semaglutide tablet for adult weight management, launching in January 2026.
Read More
DNA-Based ‘Smart’ Drug Targets Cancer Cells with Precision, Activates Only on Tumor Markers
Researchers developed a DNA-based drug that activates only in cancer cells expressing two tumor markers, improving targeted treatment precision.
Read More
Fasting-Mimicking Diet Provides Real Relief in New Crohn’s Disease Clinical Trial
A Stanford trial found a five-day monthly fasting-mimicking diet improved symptoms and remission in 69% of Crohn’s disease patients.
Read More
Aging Lung Cells Trigger Dangerous Immune Overresponse to Flu and COVID in Older Adults, Study Finds
A UCSF study finds aging lung cells trigger harmful immune overreactions to flu and COVID-19 in older adults, worsening lung damage.
Read More
ASH Highlights PDUFA Dates for Subcutaneous Istuximab in Myeloma, CAR T-Cell Therapy for AML/ALL/MDS
The FDA set an April 23, 2026 PDUFA date for subcutaneous isatuximab in relapsed/refractory multiple myeloma, following positive phase 3 trial results.
Read More